Search Results
Exercise for blood cancer patients
Table of contents:
Gilteritinib
Gilteritinib is a indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.
Brexucabtagene autoleucel
Brexucabtagene autoleucel is FDA approved for the treatment of
- Adult patients with relapsed or refractory mantle cell lymphoma (MCL).
This indication is approved under accelerated approval based on overall response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. - Adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Filgrastim
Filgrastim is FDA approved to
Nutrition Advice from a Dietitian & Blood Cancer Survivor
76-year-old Barbara Borrell is a woman who wears many hats – a 50+ year registered dietitian, nutrition consultant and educator, cancer advocate, volunteer with The Leukemia & Lymphoma Society, and a blood cancer survivor who has battled not one, not two, but three types of blood cancer.
Supporting Lifesaving Medicaid Expansion for Patients
On November 6, citizens in Idaho, Nebraska, and Utah approved ballot measures to expand Medicaid in their states. These landmark votes will close the coverage gap for more than 360,000 people in these states who earn too much to qualify for traditional Medicaid but not enough to get help with the cost of buying individual coverage.
Heart Disease in Lymphoma Survivors
Matthew Matasar is a hematology and oncology specialist at Memorial Sloan-Kettering Cancer Center in New York City. He has a Translational Research Program grant through The Leukemia & Lymphoma Society and is investigating which Hodgkin lymphoma survivors are at greater risk for developing heart disease after receiving radiation therapy to the chest and what diagnostic tests are best.
Sargramostim
Sargramostim is FDA approved
Tisagenlecleucel
Tisagenlecleucel is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of
Ultra-Endurance Athlete Takes on 1000-Mile Iconic Race for Cancer Cures
52-year-old Steve Cannon from Iowa refers to himself as an adventurer, but when you look at his track record of accomplishments, media, spectators and fans across the country refer to him as a beast. He was the first-ever athlete to run around Lake Michigan and averaged a marathon a day for 40 straight days totaling 1,037 miles. He’s also completed a 350-mile bike ride and took on the world’s longest Kayak race – just to list a few.
Small Steps Make Big Impact for Moms In Training
Getting the courage to work out is often harder than the workout itself. This is especially true when fitness plans include goals that are hard to measure. Fortunately, through a special partnership with Fitbit, many women in The Leukemia & Lymphoma Society's (LLS) Moms In Training program are learning to better manage their workouts and track their progress.
RESEARCH NOW: 9/11 AND BLOOD CANCER RISK IN FIRST RESPONDERS
All of us were impacted by the tragedy of September 11. For those who dedicated countless hours to rescue, recovery, and clean-up efforts, the effects of that devastating incident continue to be a challenge. Firefighters, police officers, emergency medics and others were exposed to harmful fumes and dust in the weeks and months following that disaster.